Research ArticleCancer

The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells

See allHide authors and affiliations

Sci. Signal.  06 Aug 2013:
Vol. 6, Issue 287, pp. ra66
DOI: 10.1126/scisignal.2004155

Log in to view Figures & Data

Log in through your institution

Log in through your institution